These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8183965)

  • 1. Beta-cell function in mice injected with mononuclear splenocytes from multiple-dose streptozotocin diabetic mice.
    Arata M; Fabiano de Bruno L; Goncalvez Volpini WM; Quintans JC; D'Alessandro VG; Braun M; Basabe JC
    Proc Soc Exp Biol Med; 1994 May; 206(1):76-82. PubMed ID: 8183965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of modified diabetic splenocytes on mice injected with splenocytes from multiple low-dose streptozotocin diabetic donors.
    Arata M; Bruno L; Pastorale C; Pagliero F; Basabe JC
    Exp Biol Med (Maywood); 2001 Nov; 226(10):898-905. PubMed ID: 11682695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early manifestations in multiple-low-dose streptozotocin-induced diabetes in mice.
    Karabatas LM; Pastorale C; de Bruno LF; Maschi F; Pivetta OH; Lombardo YB; Chemes H; Basabe JC
    Pancreas; 2005 May; 30(4):318-24. PubMed ID: 15841040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nitric oxide generation: normalization of in vitro insulin secretion in mice with multiple low-dose streptozotocin and in mice injected with mononuclear splenocytes from diabetic syngeneic donors.
    Karabatas LM; Fabiano de Bruno L; Pastorale CF; Cullen C; Basabe JC
    Metabolism; 1996 Aug; 45(8):940-6. PubMed ID: 8769348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high-protein feeding on insulin secretion in mice injected with splenocytes from diabetic mice.
    Karabatas LM; Lombardo Y; Basabe JC
    Proc Soc Exp Biol Med; 1996 Jan; 211(1):81-6. PubMed ID: 8594623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of modified diabetic splenocytes on mice injected with multiple low-dose streptozotocin.
    Pastorale C; Arata M; Caminos A; Bruno L; Basabe J; Chemes H
    Exp Biol Med (Maywood); 2002 Apr; 227(4):282-9. PubMed ID: 11910051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin secretion by pancreas of athymic mice injected with peripheral mononuclear cells from insulin-dependent diabetic patients.
    Arata M; Fabiano de Bruno L; Goncalvez Volpini W; Gagliardi G; Quintans CJ; Basabe JC
    Metabolism; 1995 Nov; 44(11):1435-41. PubMed ID: 7476331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.
    Paik SG; Fleischer N; Shin SI
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6129-33. PubMed ID: 6449703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain amino acid-enriched diet: effects on insulin secretion and cellular immune aggression.
    Karabatas LM; De Bruno LF; Pastorale C; Lombardo YB; Basabe JC
    Proc Soc Exp Biol Med; 2000 Jul; 224(3):159-65. PubMed ID: 10865231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.
    McEvoy RC; Andersson J; Sandler S; Hellerström C
    J Clin Invest; 1984 Sep; 74(3):715-22. PubMed ID: 6088584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclosporin on autoimmune diabetes induced in mice by streptozotocin: beta cell-toxicity and rebound of insulitis after cessation of treatment.
    Sai P; Maugendre D; Loreal O; Maurel C; Pogu S
    Diabete Metab; 1988; 14(4):455-62. PubMed ID: 3066654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.
    Rahavi H; Hashemi SM; Soleimani M; Mohammadi J; Tajik N
    J Diabetes Res; 2015; 2015():878535. PubMed ID: 25893202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of differential survival of syngeneic islets transplanted into hyperglycemic C57BL/6J versus C57BL/KsJ mice.
    Leiter EH
    Transplantation; 1987 Sep; 44(3):401-6. PubMed ID: 2957837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of helper and/or cytotoxic T-lymphocyte depletion on low-dose streptozocin-induced diabetes in C57BL/6J mice.
    Dayer-Métroz MD; Kimoto M; Izui S; Vassalli P; Renold AE
    Diabetes; 1988 Aug; 37(8):1082-9. PubMed ID: 3260567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of immunosuppression on streptozotocin-induced diabetes in C57BL/KsJ mice.
    Leiter EH; Beamer WG; Shultz LD
    Diabetes; 1983 Feb; 32(2):148-55. PubMed ID: 6219026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice.
    Linn T; Loewk E; Schneider K; Federlin K
    Diabetologia; 1993 Dec; 36(12):1245-51. PubMed ID: 8307251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse.
    Thivolet CH; Goillot E; Bedossa P; Durand A; Bonnard M; Orgiazzi J
    Diabetologia; 1991 May; 34(5):314-9. PubMed ID: 1864485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An H-2 alloantiserum preserves beta-cell function in mice made diabetic by low-dose streptozocin.
    Bonnevie-Nielsen V; Lernmark A
    Diabetes; 1986 May; 35(5):570-3. PubMed ID: 3514332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific immunity to streptozocin. Cellular requirements for induction of lymphoproliferation.
    Klinkhammer C; Popowa P; Gleichmann H
    Diabetes; 1988 Jan; 37(1):74-80. PubMed ID: 2961642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.